Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol, in Mild Asthma
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 10 Aug 2018
At a glance
- Drugs Nadolol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Invion
- 02 Nov 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 18 Aug 2015 Planned primary completion date changed from 1 Jun 2015 to 1 Apr 2016 as reported by ClinicalTrials.gov.
- 11 Mar 2013 New trial record